Skip to main content
. 2005 Oct 11;93(8):896–904. doi: 10.1038/sj.bjc.6602800

Table 2. Characteristics of patients.

Variable 5FU n=308 5FU-LEV n=357 5FU-FA n=312 5FU-FA-LEV n=350 Total n=1327
Median age (range), years 61 (22–76) 61 (26–78) 61 (26–76) 60 (25–76) 61 (22–78)
           
Gender, n (%)
 Male 157 (51) 173 (48) 164 (53) 210 (60) 704 (53)
 Female 151 (49) 184 (52) 148 (47) 140 (40) 623 (47)
           
Site, n (%)
 Colon 242 (79) 292 (82) 245 (79) 292 (83) 1071 (81)
 Rectum 66 (21) 65 (18) 67 (21) 58 (17) 256 (19)
           
AJCC/UICC stage, n (%)
 II 144 (47) 166 (46) 145 (46) 169 (48) 624 (47)
 III 164 (53) 190 (53) 167 (54) 180 (51) 701 (53)
 Unknown 1 (<1) 1 (<1) 2 (<1)
           
Tumour type, n (%)
 Adenocarcinoma 252 (82) 286 (80) 256 (82) 278 (79) 1072 (81)
 Mucinous 23 (7) 30 (8) 19 (6) 27 (8) 99 (7)
 Other 5 (2) 2 (1) 3 (1) 4 (1) 14 (1)
 Unknown 28 (9) 39 (11) 34 (11) 41 (12) 142 (11)
           
Tumour grade, n (%)
 Well differentiated 18 (6) 21 (6) 6 (2) 17 (5) 62 (5)
 Intermediate 213 (69) 227 (64) 216 (69) 237 (68) 893 (67)
 Poorly differentiated 41 (13) 52 (15) 44 (14) 49 (14) 186 (14)
 Unknown 36 (12) 57 (16) 46 (15) 47 (13) 186 (14)
           
Site and period of trial coordination, n (%)
 Naples, before fusion 56 (18) 56 (16) 54 (17) 56 (16) 222 (17)
 Rome, before fusion 46 (13) 50 (14) 96 (7)
 Naples, after fusion 202 (66) 195 (55) 200 (64) 197 (56) 794 (60)
 Rome, after fusion 50 (16) 60 (17) 58 (19) 47 (13) 215 (16)